NCT06521281Completed
The Effect of Chan-Chuang Qigong on Fatigue, Exercise Capacity and Quality of Lifpatients With Heart Failure
The Effect of Chan-Chuang Qigong on Fatigue, Exercise Capacity and Quality of Life in Patients With Heart Failure
Source: ClinicalTrials.gov · Last updated 25 Jul 2024
Brief summary (registry, in English)
This study aimed to investigate the impact of Chan-Chuang Qigong on fatigue, exercise capacity, quality of life, and heart function in heart failure patients. The study recruited 72 heart failure patients from a medical center in northern Taiwan for an experimental study. The participants were randomly divided into two groups: patients in experimental group was given twice daily, every 15 minutes Chan-Chuang qigong, control group received the regular care for heart failure patients. Data was collected using the Piper Fatigue Scale, a six-minute walking test, and the Minnesota Living with Heart Failure Questionnaire before the intervention as the baseline, and at the 4th, 8th, and 12th weeks during the intervention. It is hoped that through this study, we can understand the effect of Chan-Chuang qigong on improving fatigue, exercise capacity and quality of life in patients with heart failure, and provide an additional choice and reference for the treatment and care of patients with heart failure in the future, and recommend future treatment of heart failure.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 72 (actual)
- First submitted
- 10 Jul 2024
- Start date
- 16 Sept 2022
- Primary completion date
- 25 Nov 2023
- Lead sponsor
- Chia-Lin Hsieh
- Diseases
- Heart failure
- NCT number
- NCT06521281
What you commit to
- Study type: Interventional
- Participants enrolled: 72
- From 16 Sept 2022 to the primary completion date, 25 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Renal failure treated with hemodialysis
Other illness
- Severe arrhythmias, such as third-degree atrioventricular block, frequent ventricular pulses and heartbeats greater than 130 beats/min at rest
- About to undergo coronary interventional surgery or cardiac surgery within 3 months
- Coronary interventional surgery or cardiac surgery in the past 3 months
Who the study is looking for
- at least 20 years of age.
- Cardiology specialist diagnoses heart failure based on clinical examination
- Heart failure classified as New York Heart Association class II (NYHA II)
- Left ventricular ejection volume \<50% (HFmrEF and HFrEF)
- According to the doctor's assessment, it is not appropriate to exercise
- Clear consciousness and ability to communicate
- Agree to participate in this study after explanation and sign the consent form
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hsieh Chia Lin Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.